Sangamo Therapeutics will reduce its workforce by 27%, announcing Wednesday plans to trim its research and stop certain manufacturing operations in an effort to redirect resources toward a narrower slate of programs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,